Human polyomaviruses in psoriasis patients on biologic treatment

abstract in e-form
Creative Commons License IconCreative Commons BY IconCreative Commons SA Icon
Thumbnail
File can be accessed.Get publication
Author
Saláková, MartinaORCiD Profile - 0000-0003-0827-1211WoS Profile - N-4288-2017Scopus Profile - 23012783400
Rob, FilipORCiD Profile - 0000-0001-5257-205XScopus Profile - 56418306600
Hugo, JanORCiD Profile - 0000-0002-4341-3812
Šmahelová, JanaORCiD Profile - 0000-0002-9164-4279WoS Profile - N-4284-2017Scopus Profile - 8543159300
Hamšíková, Eva
Ludvíková, Viera
Gkalpakiotis, SpyridonORCiD Profile - 0000-0002-6956-5961WoS Profile - P-3139-2016Scopus Profile - 18133250600
Boháč, PetrScopus Profile - 57195126411
Tachezy, RuthORCiD Profile - 0000-0001-7689-9727WoS Profile - H-3785-2017Scopus Profile - 6701593451
MZ Events Srl

Publication date
2023
Published in
Neuveden
Metadata
Show full item record
Collections
Abstract
Biologic therapy poses a higher risk of viral infection for patients, however current knowledge of human polyomavirus infection in psoriasis patients is stilllimited. In this study, we evaluate the prevalence of BK polyomavirus (BKPyV), JC polyomavirus (JCPyV) and Merkel cell polyomavirus (MCPyV) in the group of psoriasis patients treated with biologics or topical therapy.
Keywords
psoriasis, polyomavirus, BKPyV, JCPyV, MCPyV
Permanent link
https://hdl.handle.net/20.500.14178/2035
License

Full text of this result is licensed under: Creative Commons Uveďte původ-Zachovejte licenci 4.0 International

Show license terms